EUVIMED · CrossrefJournal
Metabolic Syndrome and Related Disorders
ISSN 1540-4196 · SAGE Publications
Latest articles
Longitudinal Changes in Triglyceride Glucose–Chinese Visceral Adiposity Index and Incident Cardiovascular Disease in Chinese Adults Aged 45 Years and Older: A Prospective Cohort Study from CHARLS with GBD 2021 Context
Measuring Cardiac Autonomic Function Directly in GLP-1 Receptor Agonist Users: Heart Rate Variability Beyond Composite Allostatic Load
Uric Acid and Grip Strength as Predictors of Mortality in Older Adults: A Sex-Stratified Analysis
Clinical Utility of the Atherogenic Plasma Index for Identifying Atherogenic Dyslipidemia: A Large Cross-Sectional Analysis Stratified by Sex and Thyroid Status
Immunometabolic Score AISI, UHR, RDW-to-Triglycerides and LDL-c-to-HDL-c Ratios as Early Markers of Cardiometabolic Risk in a Young Mexican Population with Elevated Waist-to-Height Ratio
Cardiac Effects of Combined Versus Individual Interventions of Mediterranean Diet and Exercise in Adults with the Hypertriglyceridemic Waist Phenotype: A Randomized Trial
Association Between Hemoglobin Concentration and Metabolic Syndrome in a Japanese Population
Telephone-Based Motivational Interviewing for People with Metabolic Syndrome: A Mixed Methods Feasibility Study
The Mediating Role of Atherogenic Index of Plasma in the Association Between Dietary Inflammatory Index and Metabolic Syndrome: Evidence from NHANES and CHARLS
Visual and Neurological Outcomes Following Glucagon-Like Peptide-1 Receptor Agonist Therapy and Bariatric Surgery in Idiopathic Intracranial Hypertension: A Network Meta-Analysis
Can the Diagnosis of Metabolic Syndrome and the Severity of the Disease Be Determined with the Help of Inflammatory Biomarkers?
Patatin-Like Phospholipase Domain-Containing Protein 3 rs2896019 and MASLD Susceptibility and Severity in Adults: A Systematic Review and Meta-Analysis of Case–Control Studies
Pregnancies Affected by Diabetes in Teenagers and Emerging Adults: A Population-Based Study
Sex-Specific Associations of Android and Gynoid Adiposity with Prediabetes Among U.S. Adults: A Cross-Sectional Analysis of National Health and Nutrition Examination Survey 2011–2016
Dissociation Between Hepatic Steatosis and Paraspinal Myosteatosis on Quantitative MRI
Adiposity Measures Derived from Bioelectrical Impedance are Associated with Cardiometabolic Markers in Women with Polycystic Ovary Syndrome
Joint Impact of Body Mass Index and High-Sensitivity C-Reactive Protein on Metabolic Dysfunction–Associated Steatotic Liver Disease Risk in Type 2 Diabetes
Dynamic Changes in Metabolic Syndrome Severity Score and Its Components with Risk of Type 2 Diabetes Mellitus: Insights from Joint Longitudinal and Survival Modeling
The Relationship Between Cognitive Function and Micronutrient Levels in Non-Geriatric Patients with Type 2 Diabetes Mellitus
Inflammatory Gene Expression, Insulin Resistance, and Circulating Markers Vary by Visceral Adiposity in Patients with Metabolic Dysfunction–Associated Steatotic Liver Disease
Fibroblast Growth Factor 21 Resistance and Metabolic Dysfunction–Associated Steatotic Liver Disease
Association of Vaspin rs2236242 with Metabolic Syndrome: A Meta-Analysis of Case–Control Studies
Allostatic Load in Patients with Type 2 Diabetes Treated with GLP-1 Receptor Agonists
Sterol Regulatory Element-Binding Proteins and Metabolic Diseases: Mechanisms, Implications, and Therapeutic Strategies
Association of Variants and Haplotypes in ADIPOQ , and Serum Adiponectin Levels with Metabolic Syndrome and Its Components in Mexican Adolescents
Gestational Diabetes Mellitus: The Impact of Body Mass Index on Clinical Outcomes
A Comparative Evaluation of Adiposity Indices for Predicting Visceral Adipose Tissue Magnitude: Insights from NHANES 2011–2018
Lipid Accumulation Product Outperforms BMI and Waist Circumference in Metabolic Disorders
Association Between Remnant Cholesterol and Nonalcoholic Fatty Liver Disease: A Systemic Review and Meta-Analysis
Are Oxidative Stress Biomarkers Reliable Part of Multimarker Panel in Female Patients with Type 2 Diabetes Mellitus?
EUVIMED